NOV Inc. Reports Q1 2025 Results: Sales Down 2%, Net Income Drops 39% to $73M, EPS Falls to $0.19

Reuters
29 Apr
NOV Inc. Reports Q1 2025 Results: Sales Down 2%, Net Income Drops 39% to $73M, EPS Falls to $0.19

NOV Inc. reported first quarter 2025 results, revealing revenues of $2.10 billion, a decline of two percent compared to the first quarter of 2024. Net income decreased by 39 percent to $73 million, or $0.19 per share. Despite the revenue drop, the company achieved a five percent increase in Adjusted EBITDA to $252 million, representing 12.0 percent of sales. NOV returned $109 million to shareholders through share repurchases and dividends during the quarter. The company faced macroeconomic challenges, including global trade tensions and a weakening economic outlook, but managed to enhance profitability and working capital efficiency. Looking ahead, NOV expects second quarter 2025 consolidated revenues to decrease by one to four percent year-over-year, with Adjusted EBITDA projected to range between $250 million and $280 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NOV Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250428366553) on April 28, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10